Parker Singleton

dad - senior scientist at - psychedelics and other fun stuff - aspiring urban homesteader -

[Parker Singleton @singletonion]

🍄 Our first https://t.co/ICdlySqJJl living systematic review and meta-analysis on psilocybin for depression is out now in @NatMentHealth. Here's what we found and the open science infrastructure we built to support it: 🧵

Open-Access Link: https://t.co/PhU4tad8Q8

[Ruben Laukkonen @RubenLaukkonen]

a very clear articulation of synergy in the brain and why it's key for human-level cognition and consciousness from @loopyluppi

[Parker Singleton @singletonion]

@RCarhartHarris Looks a bit like regression to the mean.

[will brown @willccbb]

hey mind reviewing these real quick

[Parker Singleton @singletonion]

Nice article on our recent Nature Mental Health paper: https://t.co/hOiPhSOZqz

[brutal south @Paul_Bowers]

NY Post finding out about Asheville crust punks in Year of Our Lord 2026

[Steven Meisler @StevenMeisler]

Diffusion MRI (dMRI) is a powerful tool to study white matter maturation. In our new preprint, we process and distribute a new resource of >24,000 ABCD dMRI scans using open source tools! We then evaluate how methods shape inferences about development.
🔗 https://t.co/XzEFQQj6i9

[Ted Satterthwaite @sattertt]

Incredible work by the absolutely stellar Brooke Sevchick and @singletonion — the second installment of our open-science living meta-analysis of psychedelics for mental health; check out https://t.co/Fui5SuqW4y.

[Parker Singleton @singletonion]

Huge shout out to co-first author Brooke Sevchik, Analiese Lahey, Pim Cuijpers, @MathiasHarrer, Megan Jones, @sdpnayak, Eric Strain, @VandyAtVandy, @ExistWell, Bob Dworkin, Cobb Scott, and @sattertt.

[Parker Singleton @singletonion]

🍄 Our second installment of https://t.co/ICdlySqJJl, a living systematic review and meta-analysis on MDMA for PTSD is now live on medRxiv. Here's what we found and how we built upon our open science infrastructure to support it 🧵

https://t.co/KSUPAKJdjW

[Parker Singleton @singletonion]

In partnership with https://t.co/Ahg64fHvAd, we built an interactive dashboard for exploring the data. Users can:
• Filter studies by characteristics
• Test different analysis parameters
• Test moderators
• Download figures and reports
Dashboard: https://t.co/n7nxEdtY8p

[Eric Topol @EricTopol]

Two systematic, meta-analyses on psychedelic drugs today
Brain Circuit Function @NatureMedicine
https://t.co/nBmjreYEXU
Depression @NatMentHealth
https://t.co/zJR06AsC0Z

[Ted Satterthwaite @sattertt]

Beyond delighted to see this paper -- our first from the SYPRES initiative -- now out at Nature Mental Health. Check out Parker's awesome explainer below, w/ links to dashboard + all code + data.

[Parker Singleton @singletonion]

Huge shout out to co-first author Brooke Sevchik, Analiese Lahey, Pim Cuijpers, @MathiasHarrer, Megan Jones, @sdpnayak, Eric Strain, @VandyAtVandy, Bob Dworkin, Cobb Scott, and @sattertt.

[Parker Singleton @singletonion]

🍄 Our first https://t.co/ICdlySqJJl living systematic review and meta-analysis on psilocybin for depression is out now in @NatMentHealth. Here's what we found and the open science infrastructure we built to support it: 🧵

Open-Access Link: https://t.co/PhU4tad8Q8

[Parker Singleton @singletonion]

We recently added all of the above resources accompanying our second installment on MDMA for PTSD symptoms, currently a pre-print: https://t.co/KSUPAKJdjW